Tara M. Breslin, Nora A. Janjan, Jeffrey E. Lee, Peter W. T. Pisters, Robert A. Wolff, James L. Abbruzzese, Douglas B. Evans

Pancreatic Tumor Study Group: Departments of Surgical Oncology (TMB, JEL, PWTP, DBE), Radiation Oncology (NAJ), and Gastrointestinal Oncology and Digestive Diseases (RAW, JLA), The University of Texas M. D. Anderson Cancer Center, Houston, TX

Received 6/4/98 Accepted 5/5/98

10. REFERENCES

1. D.B. Evans, J.L. Abbruzzese, & T.A. Rich: Cancer of the pancreas. In: Cancer: Principles and Practice of Oncology. Eds: DeVita VT Jr, Hellman S, Rosenberg SA , Lippincott, Philadelphia, (1997)

2. Foo M, Gunderson L, Nagorney D, McLlrath D, Van Heerden J, Robinow J, Kvols, L, Garton, G, Martenson, J, & Cha, S: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys 26, 483-489 (1993)

3. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59, 2006-10 (1987)

4. Hoffman J, Lipsitz S, Pisansky T, Weese J, Solin L, & Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 16: 317-23 (1987)

5. Kalser M, & Ellenberg S: Pancreatic cancer. adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120, 899-903 (1985)

6. Staley C, Lee J, Cleary K, Abbruzzese J, Fenoglio C, Rich T, & Evans, D. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171, 118-25 (1996)

7. Whittington R, Bryer M, Haller D, Solin L, & Rosato E: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21, 1137-43 (1991)

8. Yeo C, Abrams R, Grochow L, Sohn T, Ord S, Hruban R, Zahurak M, Dooley W, Coleman J, Sauter P, Pitt H, Lillemoe K, & Cameron J. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 225: 621-33 (1997)

9. Spitz F, Abbruzzese J, Lee J, Pisters P, Lowy A, & Fenoglio C: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15, 928-37, (1997)

10. Willett C, Lewandrowski K, Warshaw A, Efird J, & Compton C: Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217, 144-48, (1993)

11. Lowy AM, Lee JE, Pisters PWT, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, & Evans DB. Prospective, randomized trial of octreotide to prevent pancreatic fistula following pancreaticoduodenectomy for malignant disease. Ann Surg 226, 632-41 (1997)

12. Fuhrman G, Charnsangavej C, Abbruzzese J, Cleary K, Martin R, Fenoglio C, & Evans DB: Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167, 104-11 (1994)

13. DB Evans, JE Lee, & PWT Pisters: Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Mastery of Surgery. Eds: Nyhus LM, Baker RJ, Fishcer JF: Little, Brown and Co Boston (1996)

14. Cattell RB, & Braasch JW. A technique for the exposure of the third and fourth portions of the duodenum. Surg Gynecol Obstet 11, 379-80 (1960)

15. Robinson E, Lee J, Lowy A, Fenoglio C, Pisters P, & Evans D: Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 172, 437-38 (1996)

16. Leach SD, Lowy AM, Fuhrman GM,Lee JE, Curley SA, & Evans DB. Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy. Br J Surg 85, 611-17 (1998)

17. Fuhrman G, Leach S, Staley C, Cusack J, Charnsangavej C, Cleary K, El Naggar A, Fenoglio C, Lee J, & Evans D: Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric- portal vein confluence. Ann Surg 223, 154-62 (1996)

18. Staley C, Cleary K, & Abbruzzese J: Need for standardized pathologic staging of pancreaticoduodenectomy specimens: Pancreas 12, 373-80 (1996)

19. Evans DB, Rich T, & Byrd D: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127, 1335-1339 (1992)

20. Tepper J, Nardi G, & Sutt H: Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer 37, 1519-24 (1976)

21. Trede M, Schwall G, & Saeger H: Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211, 447-58 (1990)

22. Nitecki S, Sarr M, Colby T, & Van Heerden J: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221, 59-66 (1995)

23. Yeo C, Cameron J, Lillemoe K, Sitzmann J, Hruban R, Goodman S, Dooley W, Coleman J, & Pitt H: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221, 721-33 (1995)

24. Lillemoe K, Cameron J, & Yeo C, et al: Pancreaticoduodenectomy: Does it have a role in the palliation of pancreatic cancer? Ann Surg 223, 718-28 (1996)

25. Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman EK, Yeo CJ, Lillemoe KD, Pitt HA, Lin P,& Cameron JL. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Onc 67, 151-59 (1998)

26. Bold R, Evans DB, Hess KR, Grau AM, Sinicrope F, Cleary KR, Chiao PJ, & Abbruzzese JL. Molecular genetics of pancreatic cancer. Gastroenterology 114,S0029 (1998)

27. Gastrointestinal Tumor Study Group: A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 189, 205-8 (1979)

28. Klinkenbijl J, Sahmoud T, Pel van R, Couvreur M, Veenhof C, Arnaud J, Hennipman A, Wils J, & Jeekel J. Radiotherapy and 5-FU after curative resection for cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC GITCCG. Eur J Cancer 33 (S8), 1239 (1997)

29. Evans DB, Abbruzzese J, Cleary K, Buchholz D, & Rich T: Rapid-fractionation preoperative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinb 40, 319-23 (1995)

30. Pisters PWT, Abbruzzese JL, Cleary KR, Janjan N, Goswitz M, Rich T, Fenoglio C, Lee J, & Evans D: Pilot study of rapid-fractionation preoperative chemoradiation pancreaticoduodenectomy (PD) and intraoperative radiation therapy (IORT) for resectable pancreatic adenocarcinoma (Abstract). Proc Am Soc Clin Oncol 16, 1076 (1997)

31. Rowinsky E, & Donehower R: Paclitaxel. N Eng J Med 332, 1004-14 (1995)

32. Cortes J, & Pazdur R: Docetaxel. J Clin Oncol 13, 2643-55 (1995)

33. Safran H, King TP, Choy H, Hesketh PJ, Wolf B, Altenhein E, Sikov W, Rosmarin A, Akerley W, Radie-Keane K, Cicchetti G, Lopez F, Bland K, & Wanebo HJ: Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase I study. J Clin Oncol 15, 901-07 (1997)

34. Blanke CD, Choy H, Beauchamp D, Delbeke D, Shyr Y, Mertz H, Washington M, Johnson DH, & Leach SD: Phase I/II study of paclitaxel-based neoadjuvant chemoradiation for patients with potentially resectable adenocarcinoma of the pancreatic head (Abstract). Proc Am Soc Clin Oncol 17, 1103 (1998)

35. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, & Plunkett, W: A phase I clinical, plasma and cellular pharmacology study of gemcitabine. J Clin Oncol 9, 491-98 (1991)

36. Casper ES, Green MR, Kelsen DP, Heelan RT, Brown TD, Flombaum CD, Trochanowski B, & Tarassoff PG: Phase II trial of gemcitabine (2',2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 12, 29-34 (1994)

37. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, & Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15, 2403-13 (1997)

38. Rothenberg ML, Burris HA III, Andersen JS, Moore M, Green MR, Portenoy RK, Casper ES, Tarassoff PG, Storniolo AM, & Von Hoff DD: Gemcitabine: effective palliative therapy for pancreas cancer patients failing 5-FU (Abstract). 14, 198 (1995)

39. Lawrence TS, Chang EY, Hahn TM, Hertel LW, & Shewach DS: Radiosensitization of pancreatic cancer cells by 2', 2'-difluoro-2'-deoxycytidine. Intl J Rad Onc. Biol Physics 34, 867-72 (1996)

40. Blackstock AW, Bernard SA, Richards F, Savage P, & Tepper JE: Phase I study of concurrent radiation and twice-weekly gemcitabine in advanced/metastatic pancreatic cancer. Proc Am Soc Clin Oncol 17, 1015 (1998)

41. McGinn CJ, Smith DC, Szarka CE, Pinover WH, Loehrer PJ, Morphis JG, Nicol S, Shewach DS, Lawrence TS, & O’Dwyer PJ: A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer. 17, 1014 (1998)

42. Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PWT, Lee JE, Janjan NA, Goswitz MS, & Abbruzzese JL: Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. 17, 1091 (1998)

43. Hoffman JP, McGinn CJ, Szarka CE, Morphis JG, Cooper HS, Wilkes J, Nicol S: A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine for patients with localized, resectable pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 17, 1090 (1998)

44. Evans DB, Rich TA, Byrd DR, Cleary K, Connelly J, Levin B, Charnsangavej C, Fenoglio C, Ames F: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127, 1335 (1992)